Clinical Trials List
Protocol NumberGWOGXNA20190612-01
Not yet recruiting
2020-10-01 - 2022-09-30
Phase II
Terminated1
-
Trial Applicant
-
Sponsor
-
Trial scale
-
Update
2026/02/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
3 participants
-
Global
3 participants
